Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety, and tolerability of fixed doses
of OPC-34712 versus placebo for the treatment of adult subjects with an acute relapse of
schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.